These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2663975)

  • 1. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
    Byerley WF; Reimherr FW; Wood DR; Grosser BI
    J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine in depressed patients: a comparison with imipramine.
    Bremner JD
    J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of fluoxetine and imipramine in major depression.
    Bressa GM; Brugnoli R; Pancheri P
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():69-73. PubMed ID: 2783701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
    Stark P; Hardison CD
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):53-8. PubMed ID: 3882682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder.
    Cohn JB; Collins G; Ashbrook E; Wernicke JF
    Int Clin Psychopharmacol; 1989 Oct; 4(4):313-22. PubMed ID: 2607128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.
    Muijen M; Roy D; Silverstone T; Mehmet A; Christie M
    Acta Psychiatr Scand; 1988 Sep; 78(3):384-90. PubMed ID: 3057817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

  • 11. Onset of response in relation to outcome in depressed outpatients with placebo and imipramine.
    Khan A; Cohen S; Dager S; Avery DH; Dunner DL
    J Affect Disord; 1989; 17(1):33-8. PubMed ID: 2525576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative trial of a new antidepressant, fluoxetine.
    Levine S; Deo R; Mahadevan K
    Br J Psychiatry; 1987 May; 150():653-5. PubMed ID: 3307982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.
    Beasley CM; Holman SL; Potvin JH
    Ann Clin Psychiatry; 1993 Sep; 5(3):199-207. PubMed ID: 8281243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
    McGrath PJ; Stewart JW; Janal MN; Petkova E; Quitkin FM; Klein DF
    Am J Psychiatry; 2000 Mar; 157(3):344-50. PubMed ID: 10698808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
    Baldwin DS; Green M; Montgomery SA
    Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.